6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and 3,3a-dehydropyrazidol

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with 3,3a-dehydropyrazidol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boland, A; Gérardy, J; Mossay, D; Seutin, V	1

Other Studies

1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and 3,3a-dehydropyrazidol

Article	Year
Pre- and post-treatment with pirlindole and dehydropirlindole protects cultured brain cells against nitric oxide-induced death. European journal of pharmacology, 2003, Apr-11, Volume: 466, Issue:1-2 Topics: Animals; Antioxidants; Brain; Carbazoles; Cell Death; Cells, Cultured; Cerebral Cortex; Chromans; Drug Administration Schedule; Hippocampus; Intracellular Space; Lipid Peroxidation; Monoamine Oxidase Inhibitors; Nitric Oxide; Peroxides; Rats; Rats, Wistar	2003

Article

Year

Pre- and post-treatment with pirlindole and dehydropirlindole protects cultured brain cells against nitric oxide-induced death.

European journal of pharmacology, 2003, Apr-11, Volume: 466, Issue:1-2

Topics: Animals; Antioxidants; Brain; Carbazoles; Cell Death; Cells, Cultured; Cerebral Cortex; Chromans; Drug Administration Schedule; Hippocampus; Intracellular Space; Lipid Peroxidation; Monoamine Oxidase Inhibitors; Nitric Oxide; Peroxides; Rats; Rats, Wistar

2003